Popliteal lymph node (PLN) assay to study adjuvant effects on respiratory allergy

Methods

Volumn 41, Issue 1, 2007, Pages 72-79

  Løvik, Martinus ^a   Alberg, Torunn ^a   Nygaard, Unni Cecilie ^a   Samuelsen, Mari ^a   Groeng, Else Carin ^a   Gaarder, Per Ivar ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adjuvant; Allergy; Assay; Footpad; IgE; Mouse; PLN; Popliteal lymph node; Predictive; Respiratory

Indexed keywords

ADJUVANT; ALLERGEN; ANTIBODY; ANTICONVULSIVE AGENT; ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; PHENYTOIN; THYMIDINE;

ANTIBODY BLOOD LEVEL; ARTICLE; CELL COUNT; CELL PROLIFERATION; CYTOKINE RELEASE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FLOW CYTOMETRY; FOOD ALLERGY; FOOT PAD; HISTOLOGY; IMMUNE RESPONSE; IMMUNOASSAY; LYMPH NODE; NONHUMAN; PARTICULATE MATTER; POPLITEAL CYST; POPLITEAL LYMPH NODE; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RODENT; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DISEASE MODELS, ANIMAL; HINDLIMB; HYPERSENSITIVITY; LOCAL LYMPH NODE ASSAY; LUNG DISEASES; LYMPH NODES;

ANIMALIA;

EID: 33845342207     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2006.07.014     Document Type: Article

References (52)

1. Cuq P. Recl. Med. Vet. 142 (1966) 1211-1236
2. Tilney N.L. J. Anat. 109 (1971) 369-383
3. Rees R.J.W. Br. J. Exp. Pathol. 45 (1964) 207-218
4. Closs O. Infect Immun. 12 (1975) 480-489
5. Zinkernagel R.M. Semin Immunol. 12 (2000) 163-171
6. Shepard C.C. J. Exp. Med. 112 (1960) 445-457
7. Lovik M., and Closs O. Clin. Exp. Immunol. 75 (1989) 461-465
8. Lovik M., Haugen O.A., and Closs O. Scand. J. Immunol. 20 (1984) 227-235
9. Laskay T., Wittmann I., Diefenbach A., Rollinghoff M., and Solbach W. J. Immunol. 158 (1997) 1246-1253
10. Mackaness G.B., Auclair D.J., and Lagrange P.H. J. Natl. Cancer Inst. 51 (1973) 1655-1667
11. Ruitenberg E.J., de Jong W.H., Kreeftenberg J.G., Steerenberg P.A., Kruizinga W., and van Noorle Jansen L.M. Cancer Immunol. Immunother. 11 (1981) 45-51
12. Wedderburn N., Carter R.L., and Salaman M.H. Br. J. Cancer 34 (1976) 390-400
13. Rolstad B. Imm. Rev. 88 (1985) 153-168
14. Rolstad B. Transplantation 21 (1976) 117-123
15. Ford W.L., Burr W., and Simonsen M. Transplantation 10 (1970) 258-266
16. Gleichmann H. Clin. Immunol. Immunopathol. 18 (1981) 203-211
17. De Bakker J.M., Kammuller M.E., Muller E.S.M., Lam A.W., Seinen W., and Bloksma N. Virchows Archiv B Cell Pathol. 58 (1990) 279-287
18. Kammuller M.E., Thomas C., De Bakker J.M., Bloksma N., and Seinen W. Int. J. Immunopharmacol. 11 (1989) 293-300
19. Verdier F., Virat M., and Descotes J. Immunopharmacol. Immunotoxicol. 12 (1990) 669-677
20. Verdier F., Brouland J.-P., Virat M., and Descotes J. J. Toxicol. Clin. Exp. 10 (1990) 161-167
21. Vial T., Carleer J., Legrain B., Verdier F., and Descotes J. Toxicology 122 (1997) 213-218
22. Pieters R. Methods 19 (1999) 71-77
23. Pieters R., Ezendam J., Bleumink R., Bol M., and Nierkens S. Toxicol. Lett. 127 (2002) 83-91
24. Bloksma N., Kubicka-Muranyi M., Schuppe H.-C., Gleichmann E., and Gleichmann H. Crit. Rev. Toxicol. 25 (1995) 369-396
25. Goebel C., Griem P., Sachs B., Bloksma N., and Gleichmann E. Inflamm. Res. 45 (1996) 85-90
26. Ravel G., and Descotes J. J. Appl. Toxicol. 25 (2005) 451-458
27. Pieters R. Toxicology 158 (2001) 65-69
28. Albers R., Broeders A., Van der Pijl A., Seinen W., and Pieters R. Toxicol. Appl. Pharmacol. 143 (1997) 102-109
29. Lovik M., Hogseth A.-K., Gaarder P.I., Hagemann R., and Eide I. Toxicology 121 (1997) 165-178
30. Ormstad H., Groeng E.C., Duffort O., and Lovik M. Toxicology 188 (2003) 309-318
31. Verdier F., Patriarca C., Vial T., Virat M., and Descotes J. Pharmacol. Toxicol. II (1993) 46
32. Pieters R. Toxicol. Lett. 112-113 (2000) 453-459
33. Descotes J., Patriarca C., Vial T., and Verdier F. Toxicology 119 (1997) 45-49
34. Patriarca C., Verdier F., Brouland J.P., Vial T., and Descotes J. Hum. Exp. Toxicol. 13 (1994) 455-460
35. Descotes J., and Verdier F. In: Burleson G.R., Dean J.H., and Munson A.E. (Eds). Methods in Immunotoxicology (1995), Wiley-Liss, New York 189-196
36. Nygaard U.C., Aase A., and Lovik M. BMC Immunol. 6 (2005) 11
37. Granum B., Gaarder P.I., Eikeset A., Stensby B.A., and Lovik M. Int. Arch. Allergy Appl. Immunol. 122 (2000) 167-173
38. van Zijverden M., Van der Pijl A., Bol M., van Pinxteren F.A., de Haar C., Penninks A.H., van Loveren H., and Pieters R. Toxicol. Appl. Pharmacol. 168 (2000) 131-139
39. Nygaard U.C., Ormstad H., Aase A., and Løvik M. Toxicology 206 (2005) 181-183
40. Dybing E., Lovdal T., Hetland R.B., Lovik M., and Schwarze P.E. Toxicology 198 (2004) 307-314
41. T. Alberg, E.-C. Groeng, E. Dybing, M. Løvik, Submitted for publication (2006).
42. Nygaard U.C., Samuelsen M., Aase A., and Løvik M. Tox. Sci. 82 (2004) 515-524
43. Descotes J., Verdier F., Cordier G., and Virat M. Toxicologist 10 (1990) 528
44. Ruat C., Faure L., Choquet-Kastylevsky G., Ravel G., and Descotes J. Toxicology 188 (2003) 29-33
45. Dybing E., Løvdal T., Hetland R.B., Løvik M., and Schwarze P.E. Toxicology 198 (2004) 307-314
46. Basketter D.A., Gerberick G.F., and Kimber I. Trends Pharmacol. Sci. 22 (2001) 264-265
47. Brouland J.P., Verdier F., Patriarca C., Vial T., and Descotes J. J. Toxicol. Environ. Health 41 (1994) 95-108
48. Nygaard U.C., Alberg T., Bleumink R., Aase A., Dybing E., Pieters R., and Løvik M. Toxicology 207 (2005) 241-254
49. Tuschl H., Landsteiner H.T., and Kovac R. Toxicology 172 (2002) 35-48
50. Ravel G., Christ M., Horand F., and Descotes J. Toxicology 200 (2006) 247-254
51. Choquet-Kastylevsky G., Tedone R., and Descotes J. Hum. Exp. Toxicol. 20 (2001) 591-595
52. Clausen S.K., Sobhani S., Poulsen O.M., Poulsen L.K., and Nielsen G.D. Food Chem. Toxicol. 38 (2000) 1065-1074